| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 282.91B | 277.92B | 258.11B | 255.43B | 221.21B |
| Gross Profit | 96.75B | 99.08B | 86.61B | 90.86B | 75.59B |
| EBITDA | 20.30B | 24.91B | 25.37B | 32.06B | 24.62B |
| Net Income | 1.28B | 7.39B | 11.38B | 12.68B | 14.08B |
Balance Sheet | |||||
| Total Assets | 394.86B | 410.03B | 340.31B | 382.90B | 325.32B |
| Cash, Cash Equivalents and Short-Term Investments | 116.83B | 146.30B | 105.35B | 167.22B | 123.93B |
| Total Debt | 10.93B | 27.28B | 25.83B | 65.89B | 65.70B |
| Total Liabilities | 118.11B | 132.62B | 127.74B | 159.72B | 149.58B |
| Stockholders Equity | 248.04B | 252.22B | 190.59B | 202.55B | 171.90B |
Cash Flow | |||||
| Free Cash Flow | 689.00M | 7.20B | 5.17B | 14.71B | 19.50B |
| Operating Cash Flow | 3.42B | 13.84B | 8.30B | 17.52B | 21.71B |
| Investing Cash Flow | -20.96B | -8.37B | 3.49B | 20.01B | -7.44B |
| Financing Cash Flow | -22.51B | 44.04B | -65.80B | -5.54B | 26.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥3.71B | 3.64 | ― | 2.95% | 9.54% | 5.99% | |
71 Outperform | ¥13.71B | 16.40 | ― | 3.16% | -1.07% | -25.73% | |
62 Neutral | ¥19.15B | 33.91 | ― | 2.01% | 6.50% | 33.16% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥8.60B | 2.04 | ― | 1.06% | 7.53% | 124.36% | |
52 Neutral | ¥2.48B | -397.06 | ― | ― | 8.82% | -48.52% | |
44 Neutral | ¥451.43B | 436.21 | ― | 0.98% | 1.80% | -84.10% |